Christel Franchet
Corporate Officer/Principal bei Domain Therapeutics SA
Aktive Positionen von Christel Franchet
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Corporate Officer/Principal | - | - |
Karriereverlauf von Christel Franchet
Ehemalige bekannte Positionen von Christel Franchet
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hoffmann La Roche France | Corporate Officer/Principal | 01.01.2001 | 01.01.2001 |
Euroclide SA
Euroclide SA Miscellaneous Commercial ServicesCommercial Services Part of Domain Therapeutics SA, Euroclide SA is a French drug research company. The company was founded by Christel Franchet. Euroclide was acquired by Domain Therapeutics SA on December 22, 2003. | Gründer | 01.01.2001 | - |
Ausbildung von Christel Franchet
University of Strasbourg | Doctorate Degree |
Statistik
International
Frankreich | 5 |
Operativ
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Founder | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Hoffmann La Roche France | |
Euroclide SA
Euroclide SA Miscellaneous Commercial ServicesCommercial Services Part of Domain Therapeutics SA, Euroclide SA is a French drug research company. The company was founded by Christel Franchet. Euroclide was acquired by Domain Therapeutics SA on December 22, 2003. | Commercial Services |
- Börse
- Insiders
- Christel Franchet
- Erfahrung